• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

MAGUK proteins and junctions

MAGUK proteins and junctions

Hannelore Bauer (ORCID: )
  • Grant DOI 10.55776/P18743
  • Funding program Principal Investigator Projects
  • Status ended
  • Start April 3, 2006
  • End April 2, 2010
  • Funding amount € 237,132

Disciplines

Medical-Theoretical Sciences, Pharmacy (100%)

Keywords

    Epithelial, In vitro, Endethelial, MAGUKs, Junctions

Abstract Final report

In recent years intriguing evidence has accumulated suggesting that junctional proteins not only exert functions related to structural barrier mechanisms but are also involved in signal transduction. They receive and convert signals from the cell interior to regulate junction assembly and function, and transmit signals to the cell interior to modulate gene expression, cell growth and behavior. Zonula occludens proteins (ZOPs) are multi-domain scaffolding proteins, localizing preferentially at tight junctions. ZOPs, currently comprising ZO-1, ZO-2, and ZO- 3, are structurally similar to the membrane-associated guanylate kinase-like (MAGUK) protein family of signaling molecules. The homology of ZOPs with the Drosophila tumour suppressor protein dlgA has provided a first clue towards a yet undefined role of ZOPs in epithelial cancer development and/or progression. The molecular pathways by which the tight junction-associated ZOPs interfere with cell growth and proliferation are far from being understood. In a recent study we have shown that ZO-2 localizes to the nucleus of epithelial and endothelial cells. Using a yeast-based Two-Hybrid assay and co-immunoprecipitation we have demonstrated that ZO-2 interacts directly with the nuclear scaffold attachment factor-B (SAF-B), a co-repressor of estrogen receptor- alpha, known to regulate transcription of genes involved in proliferation, apoptosis, migration and other cellular processes. The aim of this project is to further explore the biological significance of nuclear ZO-2 in tumour and non-tumour epithelial and endothelial cells. We will elaborate our earlier findings concerning the nuclear accumulation of ZO-2 focusing on upstream and downstream events related to the aberrant localization of ZO-2 at the protein and genomic level. We will further dissect the interaction of ZO-2 with SAF-B and will focus on a possible interplay between ZO-2/SAF-B binding and estrogen receptor-alpha activity. The technical spectrum of the project will comprise cell culture and transfection experiments, confocal microscopy, site-directed mutagenesis, pathway-focused gene profiling, 2D gel electrophoresis, mass spectrometric analysis (MALDI), co-immunoprecipitation and Two-Hybrid assays.

Occluding intercellular contacts (junctions) consist of single- or multi-pass transmembrane components, connected to cytoplasmic proteins, which are collectively referred to as peripheral junctional proteins. The extracellular domains of the integral junctional proteins of two opposing cells interact in a homophilic or heterophilic manner to create a paracelluar "seal". So far, a plethora of proteins locating at the cytoplasmic surface of junctional contact sites have been discovered, the role of which has just partly been unraveled. Zonula occludens proteins (ZOPs) are peripheral, scaffolding proteins which belong to the large family of MAGUK (membrane-associated guanylate kinase-like) proteins. These multidomain proteins, currently comprising ZO-1, -2, and -3, are critically involved in the structural organization of epithelial and endothelial intercellular junctions but are also components of intracellular signaling networks. In earlier studies we have shown that ZO-2 localizes to the nucleus of cultured endothelial and epithelial cells in response to various environmental stress conditions including heat shock or chemical insult. During the last couple of years we have focused on the nuclear targeting of ZO-2 and on its intranuclear activities. To this end, we have generated epithelial and endothelial cell lines, stably overexpressing nuclear ZO-2. Following such experimentally induced nuclear accumulation of ZO-2, a series of experiments have been carried out to identify novel protein-protein interactions of nuclear ZO-2 in epithelial and endothelial cells. Our results provide evidence to suggest that accumulation of nuclear ZO-2 alters gene and protein expression of epithelial and endothelial cells. Proteins found to be increased or decreased following nuclear overexpression of ZO-2 may be related to cell metabolism, barrier function, migration and oxidative stress response. We have further shown that ZO-2 directly associates with a transcriptional regulator, known to be involved in cytoprotection during oxidative stress/hypoxia, and with a multifunctional nucleolar phosphoprotein. In addition, nuclear accumulation of ZO-2 was shown to trigger the down-regulation of a distinctive class of matrix-metalloproteinases, which was also reflected by a substantially reduced migratory activity of cells containing high levels of nuclear ZO-2. Since downregulation of such enzymes is considered to exert protective effects in ischemic/hypoxic conditions, it remains to be clarified whether nuclear targeting of ZO proteins may represent a first step in a signalling cascade elicited by oxidative stress. Taken together, our data support the notion that ZO proteins do exert a "dual "function. They support the structural organization of junctional complexes at the plasma membrane, but are also involved intracellular cell signalling and modulation of gene expression.

Research institution(s)
  • Universität Salzburg - 100%

Research Output

  • 312 Citations
  • 4 Publications
Publications
  • 2007
    Title Nuclear Zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cells
    DOI 10.1111/j.1432-0436.2007.00227.x
    Type Journal Article
    Author Traweger A
    Journal Differentiation
    Pages 99-106
  • 2008
    Title Hyperosmotic stress induces Axl activation and cleavage in cerebral endothelial cells
    DOI 10.1111/j.1471-4159.2008.05590.x
    Type Journal Article
    Author Wilhelm I
    Journal Journal of Neurochemistry
    Pages 116-126
    Link Publication
  • 2010
    Title New aspects of the molecular constituents of tissue barriers
    DOI 10.1007/s00702-010-0484-6
    Type Journal Article
    Author Bauer H
    Journal Journal of Neural Transmission
    Pages 7-21
  • 2010
    Title The Dual Role of Zonula Occludens (ZO) Proteins
    DOI 10.1155/2010/402593
    Type Journal Article
    Author Bauer H
    Journal BioMed Research International
    Pages 402593
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF